Supplementation of treated cells with SOD or inhibiting nitric oxide synthase counteracts the effectiveness of BRAF-inhibitor treatment and rescues the growth of BRAF-mutant melanoma cells [210]. This evidence concerns the gene SOD1 and melanoma.